Amodiaquine

Pediatric
  • TRADE NAMES: Basoquin; Camochin; Camoquin (Pfizer); Camoquinal; Flavoquin (Sanofi-Aventis); Miaquin
  • INDICATIONS: Malaria
  • CLASS: Anti-inflammatory, Antimalarial
  • HALF-LIFE: 15.7–19.5 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

None known

PREGNANCY CATEGORY: N/A

Our database has 26 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
ENDOCRINE/METABOLIC
HEMATOLOGIC
OCULAR
OTHER


Page last updated 05/22/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric